Trial intelligence / Profile preview

FMT in Critically Ill Patients With Severe Infections

NCT05578196Recruiting

Sponsor
Shanghai Tenth People's Hospital
Start
Sep 2022
Primary completion
Dec 2024
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised trial of fecal microbiome transplant in sepsis and Infection (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Death at 28 days. Started Sep 2022; status: recruiting.

02

Drugs

fecal microbiome transplant
03

Conditions

sepsisInfection

Beyond the preview

Go deeper on NCT05578196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05578196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call